Whole-Body MRI in Musculoskeletal Oncology: A Comprehensive Review with Recommendations.
Isabela Azevedo Nicodemos da CruzLaura Marie FayadShivani AhlawatHenrique M LedermanMarcelo Astolfi Caetano NicoAlípio Gomes Ormond FilhoJúlio Brandão GuimarãesPublished in: Radiology. Imaging cancer (2023)
Whole-body (WB) MRI has emerged as an attractive method for oncologic evaluation, potentially replacing conventional imaging modalities and providing a one-step wide-coverage assessment of both the skeleton and soft tissues. In addition to providing anatomic information, WB MRI may also yield a functional analysis with the inclusion of diffusion-weighted imaging (DWI). DWI translates microstructural changes, resulting in an excellent alternative to fluorodeoxyglucose PET/CT. WB MRI (with DWI) offers comparable accuracy to PET/CT and has the advantage of avoiding ionizing radiation. Technological advances and the development of faster protocols have prompted greater accessibility of WB MRI, with growing applications in routine practice for the diagnosis, staging, and follow-up of cancer. This review discusses the technical considerations, clinical applications, and accuracy of WB MRI in musculoskeletal oncology. Keywords: Pediatrics, MR Imaging, Skeletal-Axial, Skeletal-Appendicular, Soft Tissues/Skin, Bone Marrow, Extremities, Oncology, Musculoskeletal Imaging © RSNA, 2023.
Keyphrases
- diffusion weighted imaging
- pet ct
- contrast enhanced
- magnetic resonance imaging
- diffusion weighted
- positron emission tomography
- computed tomography
- bone marrow
- palliative care
- magnetic resonance
- gene expression
- healthcare
- primary care
- squamous cell carcinoma
- prostate cancer
- mesenchymal stem cells
- clinical practice
- lymph node
- radical prostatectomy
- health information
- papillary thyroid
- multiple sclerosis
- minimally invasive
- wound healing
- squamous cell